JP2017525371A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017525371A5 JP2017525371A5 JP2017510397A JP2017510397A JP2017525371A5 JP 2017525371 A5 JP2017525371 A5 JP 2017525371A5 JP 2017510397 A JP2017510397 A JP 2017510397A JP 2017510397 A JP2017510397 A JP 2017510397A JP 2017525371 A5 JP2017525371 A5 JP 2017525371A5
- Authority
- JP
- Japan
- Prior art keywords
- cfdna
- capture probe
- item
- genetic
- analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 57
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 239000000523 sample Substances 0.000 claims description 17
- 208000026350 Inborn Genetic disease Diseases 0.000 claims description 15
- 208000016361 genetic disease Diseases 0.000 claims description 15
- 230000002068 genetic effect Effects 0.000 claims description 15
- 230000003902 lesion Effects 0.000 claims description 13
- 238000012252 genetic analysis Methods 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 239000012472 biological sample Substances 0.000 claims description 7
- 230000008707 rearrangement Effects 0.000 claims description 7
- 238000004458 analytical method Methods 0.000 claims description 6
- 238000012163 sequencing technique Methods 0.000 claims description 5
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- 210000004381 amniotic fluid Anatomy 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 4
- 238000012217 deletion Methods 0.000 claims description 4
- 230000037430 deletion Effects 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 210000002751 lymph Anatomy 0.000 claims description 4
- 210000003097 mucus Anatomy 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 210000004243 sweat Anatomy 0.000 claims description 4
- 230000007704 transition Effects 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 238000001712 DNA sequencing Methods 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 3
- 238000007622 bioinformatic analysis Methods 0.000 claims description 3
- 210000001508 eye Anatomy 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 101150023956 ALK gene Proteins 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 6
- 230000004927 fusion Effects 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 101150068690 eml4 gene Proteins 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 238000001514 detection method Methods 0.000 description 2
- 108091023043 Alu Element Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020090411A JP7441584B6 (ja) | 2014-08-22 | 2020-05-25 | 無細胞ＤＮＡ（ｃｆＤＮＡ）の定量的遺伝子解析のための方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2014/052317 WO2016028316A1 (en) | 2014-08-22 | 2014-08-22 | Methods for quantitative genetic analysis of cell free dna |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020090411A Division JP7441584B6 (ja) | 2014-08-22 | 2020-05-25 | 無細胞ＤＮＡ（ｃｆＤＮＡ）の定量的遺伝子解析のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017525371A JP2017525371A (ja) | 2017-09-07 |
| JP2017525371A5 true JP2017525371A5 (cg-RX-API-DMAC7.html) | 2017-12-21 |
| JP6709778B2 JP6709778B2 (ja) | 2020-06-17 |
Family
ID=51494529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017510397A Active JP6709778B2 (ja) | 2014-08-22 | 2014-08-22 | 無細胞ＤＮＡ（ｃｆＤＮＡ）の定量的遺伝子解析のための方法 |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP3194612B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6709778B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN107002118B (cg-RX-API-DMAC7.html) |
| CA (1) | CA2957657A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3194612T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2984266T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE068191T2 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3194612T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3194612T (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201701113WA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016028316A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| RU2671980C2 (ru) | 2011-02-09 | 2018-11-08 | Натера, Инк. | Способы неинвазивного пренатального установления плоидности |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| US11230589B2 (en) | 2012-11-05 | 2022-01-25 | Foundation Medicine, Inc. | Fusion molecules and uses thereof |
| EP3561072A1 (en) | 2012-12-10 | 2019-10-30 | Resolution Bioscience, Inc. | Methods for targeted genomic analysis |
| US12492429B2 (en) | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| JP6659575B2 (ja) | 2014-04-21 | 2020-03-04 | ナテラ， インコーポレイテッド | 変異の検出および染色体分節の倍数性 |
| US20180173845A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| HUE056267T2 (hu) | 2014-07-18 | 2022-02-28 | Univ Hong Kong Chinese | DNS-keverékek szöveteinek metilációs mintázatelemzése |
| US20160053301A1 (en) | 2014-08-22 | 2016-02-25 | Clearfork Bioscience, Inc. | Methods for quantitative genetic analysis of cell free dna |
| JP7441584B6 (ja) * | 2014-08-22 | 2024-03-15 | レゾリューション バイオサイエンス， インコーポレイテッド | 無細胞ＤＮＡ（ｃｆＤＮＡ）の定量的遺伝子解析のための方法 |
| US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| EP4428863A3 (en) | 2015-05-11 | 2024-12-11 | Natera, Inc. | Methods and compositions for determining ploidy |
| CA3004435A1 (en) | 2015-11-11 | 2017-05-18 | Resolution Bioscience, Inc. | High efficiency construction of dna libraries |
| US11479878B2 (en) | 2016-03-16 | 2022-10-25 | Dana-Farber Cancer Institute, Inc. | Methods for genome characterization |
| WO2017181202A2 (en) | 2016-04-15 | 2017-10-19 | Natera, Inc. | Methods for lung cancer detection |
| WO2017190067A1 (en) | 2016-04-28 | 2017-11-02 | Impact Genomics, Inc. | Methods of assessing and monitoring tumor load |
| EA201892491A1 (ru) * | 2016-04-29 | 2019-06-28 | Дзе Медикал Колледж Оф Висконсин, Инк. | Пцр в реальном времени с мультиплексной оптимизированной амплификацией неправильно спаренных оснований (moma) для анализа злокачественных новообразований |
| CN106047998B (zh) * | 2016-05-27 | 2019-11-12 | 深圳市海普洛斯生物科技有限公司 | 一种肺癌基因的检测方法及应用 |
| US11832801B2 (en) * | 2016-07-11 | 2023-12-05 | Arizona Board Of Regents On Behalf Of Arizona State University | Sweat as a biofluid for analysis and disease identification |
| SG11201901371XA (en) * | 2016-08-25 | 2019-03-28 | Resolution Bioscience Inc | Methods for the detection of genomic copy changes in dna samples |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| ES2980292T3 (es) * | 2016-11-17 | 2024-09-30 | Lgc Clinical Diagnostics Inc | Métodos para preparar material de referencia y controles de ADN |
| JP2020503003A (ja) | 2016-11-30 | 2020-01-30 | ザ チャイニーズ ユニバーシティ オブ ホンコン | 尿および他のサンプルにおける無細胞ｄｎａの分析 |
| CA3067637A1 (en) | 2017-06-20 | 2018-12-27 | The Medical College Of Wisconsin, Inc. | Assessing transplant complication risk with total cell-free dna |
| CA3085933A1 (en) | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
| WO2019155050A1 (en) * | 2018-02-12 | 2019-08-15 | F. Hoffmann-La Roche Ag | Method of predicting response to therapy by assessing tumor genetic heterogeneity |
| EP3762513A1 (en) * | 2018-03-08 | 2021-01-13 | St. Johns University | Circulating serum cell-free dna biomarkers and methods |
| AU2019251504B2 (en) | 2018-04-14 | 2025-09-25 | Natera, Inc. | Methods for cancer detection and monitoring by means of personalized detection of circulating tumor DNA |
| CN108517567B (zh) * | 2018-04-20 | 2020-08-11 | 江苏康为世纪生物科技有限公司 | 用于cfDNA建库的接头、引物组、试剂盒和建库方法 |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| CN108676891B (zh) * | 2018-07-12 | 2022-02-01 | 吉林大学 | 一种直肠腺癌易感性预测试剂盒及系统 |
| US11926821B2 (en) * | 2018-10-22 | 2024-03-12 | The Chinese University Of Hong Kong | Cell-free DNA quality |
| US20220064708A1 (en) * | 2019-01-15 | 2022-03-03 | General Incorporated Association, Bio Education Laboratory | Method for preparing liquid biopsy using pva sponge |
| US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
| CN112301103B (zh) * | 2019-08-02 | 2023-04-11 | 北京贝瑞和康生物技术有限公司 | 一种非特异性扩增天然短片段核酸的方法和试剂盒 |
| CN110819622A (zh) * | 2019-10-09 | 2020-02-21 | 广州达正生物科技有限公司 | 一种快速提取石蜡组织rna的方法 |
| CN111254194B (zh) * | 2020-01-13 | 2021-09-07 | 东南大学 | 基于cfDNA的测序及数据分析的癌症相关生物标记及其在cfDNA样品分类中的应用 |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| WO2022020662A2 (en) * | 2020-07-24 | 2022-01-27 | Cornell University | Methods for assessing the severity and progression of sars-cov2 infections using cell-free dna |
| CA3189103A1 (en) * | 2020-09-08 | 2022-03-17 | Jiannan GUO | Adaptors and methods for high efficiency construction of genetic libraries and genetic analysis |
| WO2023039539A1 (en) * | 2021-09-10 | 2023-03-16 | Foundation Medicine, Inc. | Gene fusions in sarcoma |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9023769B2 (en) * | 2009-11-30 | 2015-05-05 | Complete Genomics, Inc. | cDNA library for nucleic acid sequencing |
| EP2426217A1 (en) * | 2010-09-03 | 2012-03-07 | Centre National de la Recherche Scientifique (CNRS) | Analytical methods for cell free nucleic acids and applications |
| US20130288915A1 (en) * | 2012-04-27 | 2013-10-31 | Htg Molecular Diagnostics, Inc. | Compositions and methods for alk molecular testing |
| JP2015530113A (ja) * | 2012-09-28 | 2015-10-15 | セファイド | マイクロｒｎａ多重アッセイのための２プライマーｐｃｒ |
| US20150291953A1 (en) * | 2012-11-02 | 2015-10-15 | Enzymatics Inc. | Methods and kits for nucleic acid sample preparation for sequencing |
| EP3561072A1 (en) * | 2012-12-10 | 2019-10-30 | Resolution Bioscience, Inc. | Methods for targeted genomic analysis |
| US10745686B2 (en) * | 2013-02-08 | 2020-08-18 | Qiagen Gmbh | Method for separating DNA by size |
-
2014
- 2014-08-22 CA CA2957657A patent/CA2957657A1/en active Pending
- 2014-08-22 CN CN201480081729.4A patent/CN107002118B/zh active Active
- 2014-08-22 PT PT147617625T patent/PT3194612T/pt unknown
- 2014-08-22 CN CN202210630244.2A patent/CN115029342B/zh active Active
- 2014-08-22 DK DK14761762.5T patent/DK3194612T3/da active
- 2014-08-22 EP EP14761762.5A patent/EP3194612B1/en active Active
- 2014-08-22 ES ES14761762T patent/ES2984266T3/es active Active
- 2014-08-22 PL PL14761762.5T patent/PL3194612T3/pl unknown
- 2014-08-22 EP EP24182096.8A patent/EP4410978A3/en active Pending
- 2014-08-22 SG SG11201701113WA patent/SG11201701113WA/en unknown
- 2014-08-22 WO PCT/US2014/052317 patent/WO2016028316A1/en not_active Ceased
- 2014-08-22 HU HUE14761762A patent/HUE068191T2/hu unknown
- 2014-08-22 JP JP2017510397A patent/JP6709778B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017525371A5 (cg-RX-API-DMAC7.html) | ||
| JP7119014B2 (ja) | まれな変異およびコピー数多型を検出するためのシステムおよび方法 | |
| Salk et al. | Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations | |
| EP3449019B1 (en) | Multiplexed optimized mismatch amplification (moma)-target number | |
| US11111541B2 (en) | Diagnostic MiRNA markers for Parkinson's disease | |
| JP2022002508A (ja) | 無細胞ｄｎａを評価するための多重／最適化ミスマッチ増幅（ｍｏｍａ）−リアルタイムｐｃｒ | |
| JP6328934B2 (ja) | 非侵襲性出生前親子鑑定法 | |
| JP2019504618A5 (cg-RX-API-DMAC7.html) | ||
| CN110177874A (zh) | 用于使用错配扩增和统计方法来评估风险的方法 | |
| JP2019507585A (ja) | 無細胞ｄｎａの分析による腫瘍遺伝子コピー数を決定するための方法 | |
| CA2986200C (en) | Multiplexed parallel analysis of targeted genome regions for non-invasive prenatal testing | |
| KR20180020137A (ko) | 고유 분자 색인(umi)을 갖는 용장성 판독을 사용하는 서열분석된 dna 단편의 오류 억제 | |
| JP2025028203A (ja) | 脱アミノ化に誘導される配列エラーの補正 | |
| CN106233291A (zh) | 高通量测序应用中的变体分析 | |
| US20250051850A1 (en) | Method for analyzing structural variation, primer pair set, and method for designing primer pair set | |
| JP2020188767A5 (cg-RX-API-DMAC7.html) | ||
| WO2024159118A1 (en) | Methods of hyper- and hypo-methylation analysis for disease detection | |
| Konnick et al. | Existing and Emerging Molecular Technologies in Myeloid Neoplasms | |
| HK40005635B (en) | Multiplexed optimized mismatch amplification (moma)-target number | |
| HK40005635A (en) | Multiplexed optimized mismatch amplification (moma)-target number |